Status:

Unclassified

Decision Date:

April 2023

Comments

Use as a booster dose for active immunisation to prevent COVID-19 caused by SARS-CoV-2 in individuals aged ≥12 years who have previously received at least a primary vaccination course against COVID-19.

search again